2Seventy Bio Inc(TSVT)
5.00+0.000.00%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称2Seventy Bio Inc所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况2seventy bio, Inc.于2021年4月26日在特拉华州注册成立。该公司是一家细胞和基因治疗公司，专注于癌症转化疗法的研究、开发和商业化。该公司正在推进肿瘤学的多个临床前和临床项目，并与他们的合作伙伴百时美施贵宝(BMS)一起，在批准接受至少四种先前治疗的多发性骨髓瘤患者后，向美国的多发性骨髓瘤患者提供Abecma，包括免疫调节剂、蛋白酶体抑制剂和抗CD38单克隆抗体。- 2025-05-13Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-13Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities交易所摘牌声明Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 2025-05-07Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-07Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-04-28Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend][修订]年度报告Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 2025-03-25Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2025-03-25Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-03-11Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-02-06Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-01-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2024-12-13Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
5.00
今开
5.00
量比
0.00
最低
5.00
昨收
5.00
换手率
0.00%